Pub. Date : 2021 Apr 12
PMID : 33867777
5 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
1 | The binding mechanism of ivermectin and levosalbutamol with spike protein of SARS-CoV-2. | Levalbuterol | surface glycoprotein | Severe acute respiratory syndrome coronavirus 2 |
2 | In this study, we have investigated the binding mechanism of two FDA-approved drugs (ivermectin and levosalbutamol) with the spike protein of SARs-CoV-2 using three different computational modeling techniques. | Levalbuterol | surface glycoprotein | Severe acute respiratory syndrome coronavirus 2 |
3 | Ivermectin binds with LEU492, GLN493, GLY496, and TRY505 residues in the spike protein through hydrogen bonds and levosalbutamol binds with TYR453 and TYR505 residues. | Levalbuterol | surface glycoprotein | Severe acute respiratory syndrome coronavirus 2 |
4 | Using density functional theory (DFT) studies, we have calculated the binding energies between ivermectin and levosalbutamol with residues in spike protein which favor their binding are - 22.4 kcal/mol and - 21.08 kcal/mol, respectively. | Levalbuterol | surface glycoprotein | Severe acute respiratory syndrome coronavirus 2 |
5 | Three different computer modeling techniques reveal that ivermectin is more stable than levosalbutamol in the active site of spike protein where hACE2 binds. | Levalbuterol | surface glycoprotein | Severe acute respiratory syndrome coronavirus 2 |